SOUTH SAN FRANCISCO, Calif., Nov. 16, 2021 (GLOBE NEWSWIRE) -- VistaGen Therapeutics, Inc. (NASDAQ: VTGN), a biopharmaceutical company committed to…
AGOURA HILLS, CA, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ("Oncotelic" or the "Company") (OTCQB:OTLC), a leading developer…
YARDLEY, Pa., Nov. 16, 2021 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose…
Assay developed using Abyssinia proprietary antibodies shows promise as sensitive and specific companion diagnosticFurther pre-clinical data hints at potential therapeutic…
VisitPay to offer a seamless and complete payment experience for Adventist Health patients expanding the reach of R1’s Entri™ platformMURRAY,…
With 25+ years of experience, Dr. Scaria has led numerous gene therapy programs from early research into clinical development Dr. Scaria…
Plans to submit an IND to support a Phase 2b clinical trial for COYA101HOUSTON, Nov. 16, 2021 (GLOBE NEWSWIRE) --…
SOTIO Biotech licenses LegoChem Biosciences (LCB) technology for five new antibody-drug conjugate (ADC) programsRights to LCB’s ADC platform acquired for…
SAN DIEGO, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on…
VANCOUVER, British Columbia, Nov. 16, 2021 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF…